Dr. Ramiro Jose Madden-Fuentes, MD

Dr. Madden-Fuentes practices at Concord Hospital in Concord, New Hampshire, part of Concord Hospital Health System.

Dr. Madden-Fuentes' NPI, 1861719528, was assigned on April 21, 2010. Dr. Madden-Fuentes graduated from Baylor College of Medicine in 2010. Dr. Madden-Fuentes holds New Hampshire license 18003.

Dr. Madden-Fuentes' primary practice is Concord Hospital, at 250 Pleasant St, Concord, NH 03301 in Merrimack County. The practice phone is (603) 225-2711.

Dr. Madden-Fuentes' primary practice is Concord Hospital in Concord, New Hampshire, part of Concord Hospital Health System. Dr. Madden-Fuentes is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is Concord Hospital. Dmand AI also links Dr. Madden-Fuentes to 3 more hospitals, 3 medical groups, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Madden-Fuentes practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Madden-Fuentes' primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Madden-Fuentes' licenses on file in 2 states: New Hampshire and North Carolina.

CMS data shows 769 Medicare services from Dr. Madden-Fuentes across 9 procedure codes in 2024, for 340 Medicare patients. Medicare paid $34,383 for them.

CMS counts 340 Medicare patients who saw Dr. Madden-Fuentes in 2024. The largest group is 65 to 74, with 160 patients. 68% of them have high cholesterol, and 65% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Madden-Fuentes' median patient age at 66, with 9% women.

In 2024, Dr. Madden-Fuentes wrote 1,221 Medicare Part D claims for 322 patients. 89% of them were for generic drugs. CMS names the drug for 1,119 of them, across 23 drugs with 11 or more claims each, at $100,184 in total drug cost. In 2023, CMS named 1,120 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Madden-Fuentes for performance year 2024, reported through an alternative payment model (APM). Dr. Madden-Fuentes accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Madden-Fuentes, published from 2012 to 2020. 2017 was the busiest year, with 3. The most frequent topics are Urinary Tract Infections, Spinal Dysraphism and Urethra. Dr. Madden-Fuentes has published most often in Urology. Dr. Madden-Fuentes' most frequent co-authors are Sherry Sedberry Ross, MD, Unwanaobong Unyime Nseyo, MD and Zarine Rohinton Balsara, MD, PhD.

CMS Open Payments shows 97 general payments to Dr. Madden-Fuentes from 5 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 83% of the total. Boston Scientific Corporation paid the most, $82,229.

Dr. Madden-Fuentes graduated from Baylor College of Medicine in 2010.